Physician profile
Michael A Russo
NPI 1700084381
$23,708.15
in general payments reported to CMS, 2019-2025
13 companies · $898 in 2025
The $898 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $98.26 · 2021: $1,226 · 2022: $15K · 2023: $3,141 · 2024: $2,229 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,578 · Travel and Lodging: $2,513 · Gift: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,578.19 |
| Travel and Lodging | $2,512.81 |
| Gift | $176.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,497.45 | 2021-2025 | Signia, Ligasure, Sonicision |
| Intuitive Surgical, INC. | $5,267.75 | 2021-2025 | Da Vinci Surgical System |
| Covidien LP | $1,471.37 | 2019-2020 | |
| Apollo Endosurgery US INC | $860.59 | 2022 | |
| Ethicon US, LLC | $158.02 | 2019-2023 | Echelon Flex, Dermabond Prineo, Vistaseal |
| Novo Nordisk INC | $137.86 | 2019-2022 | |
| Cardiovascular Systems INC. | $134.08 | 2021 | |
| Tela Bio, INC. | $57.29 | 2022 | |
| Abbvie INC. | $46.14 | 2024 | |
| Olympus America INC. | $31.69 | 2021 | |
| Merck Sharp & Dohme LLC | $22.11 | 2020 | |
| Teleflex LLC | $19.00 | 2023 | Titan Sgs Standard Gastric Stapler |
| Intra-Sana Laboratories | $4.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.